Showing results (311-320 of 334) with videos related to
Sort By:
Pageof 34
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.Journal for Immunotherapy of Cancer|January 4, 2024
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancerNo-Joon Song, Karthik B Chakravarthy, Hyeongseon Jeon, et al.Science Translational Medicine|October 30, 2015
IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapyEe W Su, Caitlin J Moore, Samantha Suriano, et al.Science Translational Medicine|January 10, 2020
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-βAlessandra Metelli, Bill X Wu, Brian Riesenberg, et al.Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.Journal for Immunotherapy of Cancer|January 12, 2022
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunityAubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy VolunteersMark P Rubinstein, Cameron Williams, Caroline Mart, et al.Science Advances|September 16, 2020
Identification of human CD4+ T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.Oncoimmunology|August 19, 2021
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignanciesHannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, et al.Pageof 34